An analysis of 18 separate studies found that overall, being older, belonging to a minority group, being uninsured and suffering from multiple health problems are patient characteristics associated with late referral. In addition, a lack of communication between referring physicians and nephrologists also contribute to the problem. The findings were published online this week by BioMed Central Nephrology.
Research has shown that the progression from chronic to end-stage kidney disease, which requires dialysis treatments, can be slowed if kidney damage is detected and treated early. Care by nephrologists, who specialize in treating kidney disease, is associated with reduced rates of hospitalization and death. However, studies indicate that up to 80 percent of patients who start dialysis are referred late to nephrologists.
“Late referral has been documented as a problem for more than 15 years and, according to recent studies, is not declining,” said Sonal Singh, M.D., senior author and an assistant professor of general internal medicine. “Finding ways to address the problem has been hampered by a lack of understanding of the factors responsible.”
About 26 million Americans suffer from chronic kidney disease and it is estimated that there will be 700,000 cases of end-stage kidney disease by 2015. The National Kidney Foundation recommends that patients with kidney disease be referred to nephrologists when they reach stage 4, which is a severe decrease in kidney function.
The researchers analyzed 18 studies on late referrals and looked for trends in results. They included studies that used the National Kidney Foundation’s definition of “late” as well as studies using earlier definitions, such as referrals that were one, three or six months before dialysis was initiated.
Singh and colleagues found that in North America, increasing age was associated with late referral, with several studies showing that being over age 75 resulted in a late referral.
“One study showed that even being older than 55 is associated with late referral so it is prudent to assume the risk for delayed referral increases with age,” said Singh.
The researchers said that lack of provider knowledge about the appropriate timing of referral may account for more than 25 percent of late referrals.
“The study has important implications for both clinicians and policy makers,” said Singh. “In the future, referral guidelines should be prepared in collaboration with primary care physicians, and co-management approaches for chronic kidney disease need to be explored.”
Tushar Vachharajani, M.D., an interventional nephrologist at Wake Forest Baptist who was not involved in the study, said there are multiple benefits of early referral. Early treatment by a nephrologist can help slow disease progression, but even if dialysis is inevitable, an early referral gives patient and family time to plan for the treatment.
“Patients need time to prepare mentally and physically for dialysis,” he said. “Dialysis requires a 360-degree change in lifestyle.”
He also noted that end-stage kidney disease is among the most expensive to treat on a per-capital basis. “Growing health care costs makes it mandatory to practice prevention before treating a problem whenever possible,” he said.
Karen Richardson | EurekAlert!
Some brain tumors may respond to immunotherapy, new study suggests
11.12.2018 | Columbia University Irving Medical Center
Climate change and air pollution damaging health and causing millions of premature deaths
30.11.2018 | International Institute for Applied Systems Analysis (IIASA)
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy